A detailed history of Strateg Iq Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Strateg Iq Financial Group, LLC holds 57,849 shares of ABT stock, worth $6.5 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
57,849
Previous 59,539 2.84%
Holding current value
$6.5 Million
Previous $5.77 Million 10.42%
% of portfolio
0.74%
Previous 0.69%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

SELL
$90.19 - $110.4 $152,421 - $186,576
-1,690 Reduced 2.84%
57,849 $6.37 Million
Q3 2023

Oct 19, 2023

SELL
$95.53 - $114.62 $174,628 - $209,525
-1,828 Reduced 2.98%
59,539 $5.77 Million
Q2 2023

Jul 17, 2023

BUY
$100.78 - $112.29 $604 - $673
6 Added 0.01%
61,367 $6.69 Million
Q1 2023

Apr 19, 2023

SELL
$96.86 - $114.01 $387 - $456
-4 Reduced 0.01%
61,361 $6.21 Million
Q4 2022

Jan 12, 2023

SELL
$95.06 - $111.52 $475 - $557
-5 Reduced 0.01%
61,365 $0
Q3 2022

Oct 21, 2022

SELL
$96.76 - $112.03 $1.9 Million - $2.2 Million
-19,614 Reduced 24.22%
61,370 $5.94 Million
Q2 2022

Jul 27, 2022

SELL
$102.07 - $123.37 $804,107 - $971,908
-7,878 Reduced 8.87%
80,984 $8.8 Million
Q1 2022

Apr 21, 2022

BUY
$114.02 - $139.04 $143,095 - $174,495
1,255 Added 1.43%
88,862 $10.5 Million
Q4 2021

Feb 04, 2022

BUY
$115.53 - $141.46 $1.25 Million - $1.53 Million
10,819 Added 14.09%
87,607 $12.3 Million
Q3 2021

Nov 03, 2021

SELL
$116.66 - $129.06 $1.42 Million - $1.57 Million
-12,162 Reduced 13.67%
76,788 $9.07 Million
Q2 2021

Aug 03, 2021

BUY
$105.79 - $124.53 $2 Million - $2.35 Million
18,900 Added 26.98%
88,950 $10.3 Million
Q1 2021

May 04, 2021

SELL
$108.84 - $128.23 $909,140 - $1.07 Million
-8,353 Reduced 10.65%
70,050 $8.4 Million
Q4 2020

Jan 29, 2021

SELL
$105.0 - $114.42 $2.21 Million - $2.4 Million
-21,000 Reduced 21.13%
78,403 $8.58 Million
Q3 2020

Nov 02, 2020

BUY
$91.64 - $111.29 $9,164 - $11,129
100 Added 0.1%
99,403 $10.8 Million
Q2 2020

Aug 03, 2020

SELL
$76.57 - $98.0 $7,656 - $9,800
-100 Reduced 0.1%
99,303 $9.08 Million
Q1 2020

May 05, 2020

BUY
$62.82 - $91.86 $13,631 - $19,933
217 Added 0.22%
99,403 $7.84 Million
Q4 2019

Feb 03, 2020

SELL
$78.51 - $87.4 $37,056 - $41,252
-472 Reduced 0.47%
99,186 $8.62 Million
Q3 2019

Nov 01, 2019

SELL
$81.84 - $88.74 $32,736 - $35,496
-400 Reduced 0.4%
99,658 $8.34 Million
Q2 2019

Jul 29, 2019

SELL
$72.88 - $85.0 $174,401 - $203,405
-2,393 Reduced 2.34%
100,058 $8.42 Million
Q1 2019

Apr 26, 2019

SELL
$66.22 - $80.06 $163,563 - $197,748
-2,470 Reduced 2.35%
102,451 $8.19 Million
Q4 2018

Feb 06, 2019

SELL
$65.56 - $74.27 $145,543 - $164,879
-2,220 Reduced 2.07%
104,921 $7.59 Million
Q2 2018

Jul 25, 2018

BUY
$57.57 - $63.54 $6.17 Million - $6.81 Million
107,141 New
107,141 $6.54 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Strateg Iq Financial Group, LLC Portfolio

Follow Strateg Iq Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strateg Iq Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strateg Iq Financial Group, LLC with notifications on news.